Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Business Advisory Agreement

StimCell Engages Stonegate Capital Markets

Analysis based on 7 articles · First reported Sep 08, 2026 · Last updated Sep 08, 2026

Sentiment
5
Attention
1
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The agreement is a modest positive for StimCell as it may facilitate future capital raising and strategic transactions, potentially supporting its growth initiatives. For Stonegate, the engagement represents a new client relationship with potential success-based fees, though no immediate financial impact is expected.

Biotechnology Investment Banking

StimCell Energetics Inc., a biotech company focused on cellular energy and wellness products, announced on September 8, 2026, that it has entered into an Advisory Services Agreement with Stonegate Capital Partners, Inc., effective August 24, 2026. Under the agreement, Stonegate will act as a non-exclusive advisor on a best-efforts basis to identify and introduce prospective investors and strategic counterparties for potential transactions involving StimCell's assets, property, rights, debt, or equity securities. All transactions remain subject to StimCell's approval. Stonegate will receive a success-based advisory fee as a percentage of gross proceeds from any completed transaction involving its contacts, payable upon closing. The agreement has an initial three-month term and may be terminated by either party with 30 days' written notice. Any securities offering is expected to be structured under Rule 506(c) of Regulation D. This engagement is separate from StimCell's previously announced arrangement with Stonegate Capital Partners, Inc. for research coverage and institutional investor outreach.

priv
StimCell is the company entering into the advisory agreement, seeking to leverage Stonegate's investor network to fund its eBalance technology and support its next stage of growth.
Importance 100.0 Sentiment 10.0
priv
Stonegate Capital Partners is engaged as a non-exclusive advisor to identify investors and strategic counterparties for StimCell, with potential success-based fees from any completed transactions.
Importance 80.0 Sentiment 5.0
per
David Jeffs, CEO of StimCell, announced the agreement and expressed confidence that Stonegate's experience will help evaluate funding opportunities.
Importance 30.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.